(Q53852252)

21 May 2018

title

HLA class II haplotypes associated with pulmonary interstitial lesions of polymyositis/dermatomyositis in Japanese patients. (English)

1 reference

21 May 2018

0 references

0 references

Horiki T

1

1 reference

21 May 2018

Ichikawa Y

2

1 reference

21 May 2018

Moriuchi J

3

1 reference

21 May 2018

Hoshina Y

4

1 reference

21 May 2018

Yamada C

5

1 reference

21 May 2018

Wakabayashi T

6

1 reference

21 May 2018

Jackson K

7

1 reference

21 May 2018

Inoko H

8

1 reference

21 May 2018

publication date

1 January 2002

1 reference

21 May 2018

published in

Tissue Antigens

1 reference

21 May 2018

volume

59

1 reference

21 May 2018

issue

1

1 reference

21 May 2018

page(s)

25-30

1 reference

21 May 2018

Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590105.X

7 January 2021

Microvascular changes in early and advanced dermatomyositis: a quantitative study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590105.X

7 January 2021

Myositis-Specific Autoantibodies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590105.X

7 January 2021

Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR beta chain

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590105.X

7 January 2021

Factors affecting survivorship in polymyositis. A life-table study of 124 patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590105.X

7 January 2021

Polymyositis and dermatomyositis (first of two parts)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590105.X

7 January 2021

Polymyositis and dermatomyositis (second of two parts)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590105.X

7 January 2021

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590105.X

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590105.X

7 January 2021

Modified PCR-RFLP method for HLA-DPB1 and -DQA1 genotyping

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590105.X

7 January 2021

HLA-DQB1 genotyping by a modified PCR-RFLP method combined with group-specific primers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590105.X

7 January 2021

HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590105.X

7 January 2021

Multiplicity of antibodies in myositis sera

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590105.X

7 January 2021

Detection of antibodies to extractable nuclear antigens using calf thymus and rabbit thymus. A comparative study of 1000 consecutive anti-nuclear antibody positive patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590105.X

7 January 2021

Gene frequencies and haplotypic associations within the HLA region in 916 unrelated Japanese individuals

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590105.X

7 January 2021

Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American whites: a tale of two loci.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590105.X

7 January 2021

Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590105.X

7 January 2021

Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2002.590105.X

7 January 2021

10.1034/J.1399-0039.2002.590105.X

Identifiers

DOI

1 reference

21 May 2018

1 reference

21 May 2018